About Us

 Helomics is a division of Predictive Oncology Inc. Our mission is to improve the standard of care for cancer patients (especially gynecological) by harnessing the power of the patients own living tumor to help the oncologist guide treatment. We use our unique tumor drug response profiling platform, together with the latest Next Generation Sequencing (NGS)-based genomic profiling and our vast D-CHIP AI powered knowledge-base of 150,000 tumors, to generate a roadmap that provides additional context to help the oncologist personalize the patient’s treatment. We firmly believe our approach of interrogating the living tumor provides a more functional approach to precision medicine than relying on genomics alone.

© 2020 Helomics Corp. All rights reserved.

  • White Twitter Icon
  • Facebook - White Circle
  • White LinkedIn Icon